Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New taxane derivatives from Rhone-Poulenc Rorer

Nov. 27, 1996

Protegrin development candidate selected by IntraBiotics

Nov. 26, 1996

Human brain-derived protein kinase offered for licensing

Nov. 26, 1996

Interim clinical results with Ansan's cancer product

Nov. 22, 1996

New target for drug-resistant tumors identified

Nov. 22, 1996

Mercian discloses novel mitomycin

Nov. 22, 1996

Antitumor lactam isolated by Japanese researchers

Nov. 22, 1996

Vion Pharmaceuticals expands pivotal trials of new cancer treatment

Nov. 21, 1996

Taxotere approved in three additional markets

Nov. 21, 1996

Thalidomide clinical trials in brain cancer expanded

Nov. 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...